Please login to the form below

Not currently logged in
Email:
Password:

Duodopa

This page shows the latest Duodopa news and features for those working in and with pharma, biotech and healthcare.

SMC approves Amgen orphan drug for use in NHS Scotland

SMC approves Amgen orphan drug for use in NHS Scotland

The health technology assessment body also approved AbbVie's drug/device combination Duodopa (co-careldopa) for advanced Parkinson's disease. ... AbbVie will, however, have to provide the drug under a patient access scheme to improve Duodopa's

Latest news

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    and Duodopa. ... Non-US sales of drug-device combination Duodopa for Parkinson's disease grew around 25 per cent to $44m, and AbbVie said it remains hopeful of approval for the product in

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    AbbVie (formerly Abbott Laboratories) is developing an intraduodenal gel formulation of levodopa/carbidopa (LGIC; Duodopa) for the treatment of late-stage Parkinson's in patients who have failed conventional oral levodopa

  • R&D news in brief

    ìSLV308 is for less advanced stages of Parkinson's disease, while the recently acquired drug Duodopa is intended for people suffering from late-stages of the disease so there are good

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    Pfizer - Estring. Sage Healthcare - DuoDopa. Sealed Air - Sealed Air Medical Applications.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics